NCT00292084View on ClinicalTrials.gov

An Extension Study to Evaluate the Safety and Efficacy of Celgosivir and Peginterferon Alfa-2b, With or Without Ribavirin, in Patients With Chronic Hepatitis C Genotype 1 Infection

PHASE2CompletedINTERVENTIONAL
Enrollment

60

Participants

Timeline

Start Date

February 28, 2006

Study Completion Date

October 31, 2007

Conditions
Hepatitis C, Chronic
Interventions
DRUG

Celgosivir

Trial Locations (1)

Unknown

Halifax

Sponsors
All Listed Sponsors
lead

BioWest Therapeutics Inc

INDUSTRY